Gemcitabine plus cisplatin in breast cancer

ONCOLOGY

Volumn 15, Issue 2 SUPPL. 3, 2001, Pages 28-33

  Nagourney, Robert A ^a  

^a Rational Therapeutics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DEOXYCYTIDINE; DRUG DERIVATIVE; GEMCITABINE;

ARTICLE; BREAST TUMOR; CLINICAL TRIAL; FEMALE; HUMAN; METASTASIS; PHASE 1 CLINICAL TRIAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CISPLATIN; DEOXYCYTIDINE; FEMALE; HUMANS; NEOPLASM METASTASIS;

EID: 0035261248     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Cancer Facts & Figures 2000. Atlanta, American Cancer Society, 2000.
2. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 339(8784):423-424, 1992.
3. Baum M: Polychemotherapy for early breast cancer: An overview of the randomized trials. Lancet 352:930-942, 1998.
4. Stadtmauer EA, O'Neill A, Goldstein LJ, et al: Phase III randomized trial of high-dose chemotherapy and stem cell support shows no difference in overall survival or severe toxicity compared to maintenance chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil for women with metastatic breast cancer who are responding to conventional induction chemotherapy (abstract 1). Proc Am Soc Clin Oncol 18:1a, 1999.
5. Peters W, Rosner G, Vredenburgh J, et al: A prospective, randomized comparison of two doses of combination alkyating agents as consolidation after CAF in high-risk primary breast cancer involving ten or more axillary lymph nodes: Preliminary results of CALGB 9082/SWOG 9114/NCIC MA-13 (abstract 2). Proc Am Soc Clin Oncol 18:1a, 1999.
6. The Scandinavian Breast Cancer Study Group 9401: Results from a randomized adjuvant breast cancer study with high dose chemotherapy with CTCb supported by autologous bone marrow stem cells versus dose escalated and tailored FEC therapy (abstract 3). Proc Am Soc Clin Oncol 18:2a, 1999.
7. Bezwoda WR: Randomized, controlled trial of high dose chemotherapy versus standard dose chemotherapy for high risk, surgically treated, primary breast cancer (abstract 4). Proc Am Soc Clin Oncol 18:2a, 1999.
8. Stadtmauer EA, O'Neill A, Goldstein LJ, et al: Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group. N Engl J Med 342(15): 1069-1076, 2000.